In a landmark effort to streamline oversight of overlapping markets, the SEC and CFTC issued a Memorandum of Understanding ...

The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

AKB-9090, a hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor entering a Phase 1 clinical trial in acute kidney injury (AKI) associated with cardiac surgery, in the first half of 2026.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Prediction market Kalshi asks federal judge for emergency injunction against Arizona regulators over cease and desist order ...

Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...

Scientists in Shanghai have developed a potentially groundbreaking treatment for diabetes that targets the root cause of the disease rather than just its symptoms, offering hope for a functional cure.

It has long been known as the arbiter of reward in the brain, but recent findings could upend this classic theory of dopamine ...

New York, United States, March 17th, 2026, ChainwireGSR, crypto’s capital markets partner, today announced the $57 ...

Annual customer gathering of Orange Business sees launch of four key applications taking advantage of agentic artificial intelligence (AI) capabilities and emphasising the current fundamental need for ...

Beta-cyclodextrin remains the most widely produced and commercially used form, largely because of its favorable cavity size, relatively low production cost, and well-documented safety profile.

If you look at plain vanilla dividend ETFs that simply hold stocks and avoid complex derivatives strategies, the yield ceiling tends to be fairly modest. Even if you screen aggressively for high-yield ...